Contrast-enhanced ultrasounds are an effective complementary tool in following up patients who undergo endovascular repair for abdominal aortic aneurysm.
Contrast-enhanced ultrasounds are an effective complementary tool in following up patients who undergo endovascular repair for abdominal aortic aneurysm, according to a study published in the journal Radiology.
Endovascular repair for abdominal aortic aneurysm (EVAR) is performed to place an endograft into the vessel to bypass the weakened area in the aorta. Currently, routine surveillance of the stent, to watch for endoleaks that raise the risk of an aneurysm sac rupture, is done by CT angiography. However there is concern regarding the use of CTs because of related ionizing radiation and potential kidney damage from the contrast agent.
Researchers from the Hospital Clinic in Barcelona, Spain, evaluated 35 patients who underwent CT angiography and an ultrasound with a second-generation contrast agent. The smaller microbubbles in the new agent do not pass through the cells that line the inner surface of the blood vessel walls. The exams were performed at one- and six-month follow up and every year thereafter, for a total of 126 performed studies.
According to Rosa Gilabert, MD, PhD, from the Hospital Clinic, in determining the presence of an endoleak, the contrast-enhanced ultrasound had a sensitivity of 97 percent, a specificity of 100 percent, and an accuracy of 99 percent. It enabled correct classification of 26 to 33 endoleaks and did not miss any that were clinically important.
“These results support that contrast-enhanced ultrasound can be integrated into EVAR follow-up,” Dr. Gilabert said.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.